Ralaniten (Standard)
Ralaniten (Standard) is the analytical standard of Ralaniten (HY-109070). This product is intended for research and analytical applications. Ralaniten (EPI-002) is a potent and orally active antagonist of the androgen receptor-N-terminal domain (AR-NTD). Ralaniten inhibits AR transcriptional activity, with IC50 of 7.4 μM. Ralaniten can be used for the research of castration-resistant prostate cancer (CRPC).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1203490-23-6
- Formule: C21H27ClO5
- Masse moléculaire:394.89
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-138641
BavdegalutamideAR PROTAC Degrader -
HY-135794
11-KetodihydrotestosteroneAndrogen Receptor Agonist -
HY-N0790
LupeolAndrogen Receptor Inhibitor -
HY-N1943
AilanthoneAndrogen Receptor Inhibitor -
HY-15194
DimethylcurcuminAndrogen Receptor Inhibitor -
HY-N0790R
Lupeol (Standard)Androgen Receptor Inhibitor -
HY-111024
2,2,5,7,8-Pentamethyl-6-ChromanolAndrogen Receptor Modulator -
HY-136582
MasofanitenAndrogen Receptor Inhibitor -
HY-137448
RezvilutamideAndrogen Receptor Antagonist -
HY-N0475
TriptophenolideAndrogen Receptor Antagonist -
HY-70002A
N-Desmethyl enzalutamideActive Metabolite of Enzalutamide -
HY-B1405
Dehydroisoandrosterone 3-acetateAndrogen Receptor Agonist
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 1203490-23-6
-
Masse moléculaire 394.89
-
Formule C21H27ClO5
-
SMILES
CC(C1=CC=C(OC[C@H](O)CCl)C=C1)(C2=CC=C(OC[C@H](O)CO)C=C2)C
-
Synonyms
EPI-002 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Myung JK, et, al. An androgen receptor N-terminal domain antagonist for treating prostate cancer. J Clin Invest. 2013 Jul;123(7):2948-60. [Content Brief]
[2]. Yang YC, et, al. Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer. Clin Cancer Res. 2016 Sep 1;22(17):4466-77. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ralaniten (Standard) Related Classifications
HY-109070R Related Classifications
Powered by Bioz